Connect with us

Published

on

Many Americans really want to lose weight and a new poll shows nearly half of adults would be interested in taking a prescription drug to help them do so. Use Our Content

It can be republished for free.

At the same time, enthusiasm dims sharply if the treatment comes as an injection, if it is not covered by insurance, or if the weight is likely to return after discontinuing treatment, a new nationwide KFF poll found.

Those findings display the enthusiasm for a new generation of pricey weight loss drugs hitting the market and illustrate possible stumbling blocks, as users potentially must deal with weekly self-injections, lack of insurance coverage, and the need to continue the medications indefinitely.

For example, interest dropped to 14% when respondents were asked if they would still consider taking prescription medications if they knew they could regain weight after stopping the drugs.

One way to interpret that finding is people want to lose a few pounds but dont want to be on a drug for the rest of their life, said Ashley Kirzinger, KFFs director of survey methodology. The monthly poll reached out to 1,327 U.S. adults.

The U.S. represents a large market for drugmakers who want to sell weight loss prescriptions: An estimated 42% of the population is classified as obese, according to a controversial metric known as BMI, or body mass index. In the KFF poll, 61% said they were currently trying to lose weight, although only 4% were taking a prescription medication to do so.

That gap between the 4% taking any kind of prescription weight loss treatment and the number of Americans deemed overweight or obese is the sweet spot drugmakers are targeting for the new drugs, which include several diabetes treatments repurposed as weight loss drugs.

The drugs have attracted much attention, both in mainstream publications and broadcasts and on social media, where they are often touted by celebrities and other influencers. Demand jumped and supplies have become limited. About 7 in 10 adults had heard at least a little about the new drugs, according to the survey.

The newer treatments include Wegovy, a slightly higher dose of Novo Nordisks diabetes drug Ozempic, and Mounjaro, an Eli Lilly diabetes treatment for which the company is currently seeking FDA approval as a weight loss drug.

Weight loss with these injectable drugs surpasses those of earlier generations of weight loss medications. But they are also costlier than previous drugs. The monthly costs of the drugs set by the drugmakers can range from $900 to more than $1,300.

At, say, a wholesale price tag of $1,350, the tab per person could top $323,000 over 20 years. Email Sign-Up

Subscribe to KFF Health News' free Morning Briefing. Your Email Address Sign Up

The drugs appear to work by mimicking a hormone that helps decrease appetite.

Still, like all drugs, they come with side effects, which can include nausea, diarrhea, vomiting, and constipation. More serious side effects include the risk of a type of thyroid cancer, inflammation of the pancreas, or low blood sugar. Health officials in Europe are investigating reports that the drugs may result in other side effects like suicidal thoughts.

The KFF survey found that 80% of adults thought insurers should cover the new weight loss drugs for those diagnosed as overweight or obese. Just over half wanted it covered for anyone who wanted to take it. Half would still support insurance coverage even if doing so could increase everyones monthly premiums. Still, 16% of those surveyed said they would be interested in a weight loss prescription even if their insurance did not cover it.

In practice, coverage for the new treatments varies, and private insurers often peg coverage to patients BMI, a ratio of height to weight. Medicare specifically bars coverage for drugs for anorexia, weight loss, or weight gain, although it pays for bariatric surgery.

Unfortunately, a lot of insurers have not caught up to the idea of recognizing obesity as a disease, said Fatima Cody Stanford, an obesity medicine specialist at Massachusetts General Hospital and Harvard Medical School.

Employers and insurers must consider the potential costs of covering the drugs for enrollees perhaps for them to use indefinitely against the potential savings associated with losing weight, such as a lower chance of diabetes or joint problems.

Stanford said the drugs are not a miracle cure and do not work for everyone. But for those who benefit, it can be significantly life-altering in a positive way, she said.

Its not surprising, she added, that the drugs may need to be taken long term, as the idea that there is a quick fix doesnt reflect the complexity of obesity as a disease.

While the drugs currently on the market are injectables, some drugmakers are developing oral weight loss drugs, although it is unclear whether the prices will be the same or less than the injectable products.

Still, many experts predict that a lot of money will be spent on weight loss products in the coming years. In a recent report, Morgan Stanley analysts called obesity the new hypertension and predicted industry revenue from U.S. sales of obesity drugs could rise from a current $1.6 billion annually to $31.5 billion by 2030.

Julie Appleby: jappleby@kff.org, @Julie_appleby Related Topics Health Industry Pharmaceuticals Drug Costs KFF Obesity Prescription Drugs Contact Us Submit a Story Tip

Continue Reading

Sports

Hard-throwing rookie Misiorowski going to ASG

Published

on

By

Hard-throwing rookie Misiorowski going to ASG

Hard-throwing rookie Jacob Misiorowski is a National League All-Star replacement, giving the Milwaukee Brewers right-hander a chance to break Paul Skenes‘ record for the fewest big league appearances before playing in the Midsummer Classic.

Misiorowski was named Friday night to replace Chicago Cubs lefty Matthew Boyd, who will be unavailable for the All-Star Game on Tuesday night in Atlanta because he is scheduled to start Saturday at the New York Yankees.

The 23-year-old Misiorowski has made just five starts for the Brewers, going 4-1 with a 2.81 ERA while averaging 99.3 mph on his fastball, with 89 pitches that have reached 100 mph.

If he pitches at Truist Park, Misiorowski will make it consecutive years for a player to set the mark for fewest big league games before an All-Star showing.

Skenes, the Pittsburgh Pirates right-hander getting ready for his second All-Star appearance, had made 11 starts in the majors when he was chosen as the NL starter for last year’s All-Star Game at Texas. He pitched a scoreless inning.

“I’m speechless,” said a teary-eyed Misiorowski, who said he was given the news a few minutes before the Brewers’ 8-3 victory over Washington. “It’s awesome. It’s very unexpected and it’s an honor.”

Misiorowski is the 30th first-time All-Star and 16th replacement this year. There are now 80 total All-Stars.

“He’s impressive. He’s got some of the best stuff in the game right now, even though he’s a young pitcher,” said Yankees slugger Aaron Judge, who is a starting AL outfielder for his seventh All-Star nod. “He’s going to be a special pitcher in this game for a long time so I think he deserved it and it’s going be pretty cool for him and his family.”

Carlos Rodón, Carlos Estévez and Casey Mize were named replacement pitchers on the AL roster.

The New York Yankees‘ Rodón, an All-Star for the third time in five seasons, will replace teammate Max Fried for Tuesday’s game in Atlanta. Fried will be unavailable because he is scheduled to start Saturday against the Chicago Cubs.

In his final start before the All-Star game, Rodón allowed four hits and struck out eight in eight innings in an 11-0 victory over the Cubs.

“This one’s a little special for me,” said Rodón, an All-Star in 2021 and ’22 who was 3-8 in his first season with the Yankees two years ago before rebounding. “I wasn’t good when I first got here, and I just wanted to prove that I wasn’t to going to give up and just put my best foot forward and try to win as many games as I can.”

The Kansas City Royals‘ Estévez replaces Texas’ Jacob deGrom, who is scheduled to start at Houston on Saturday night. Estévez was a 2023 All-Star when he was with the Los Angeles Angels.

Mize takes the spot held by Boston‘s Garrett Crochet, who is scheduled to start Saturday against Tampa Bay. Mize gives the Tigers six All-Stars, most of any team and tied for the franchise record.

Royals third baseman Maikel Garcia will replace Tampa Bay‘s Brandon Lowe, who went on the injured list with left oblique tightness. The additions of Estévez and Garcia give the Royals four All-Stars, matching their 2024 total.

The Seattle Mariners announced center fielder Julio Rodríguez will not participate, and he was replaced by teammate Randy Arozarena. Rodríguez had been voted onto the AL roster via the players’ ballot. The Mariners, who have five All-Stars, said Rodríguez will use the break to “recuperate, rest and prepare for the second half.”

Arozarena is an All-Star for the second time. He started in left field for the AL two years ago, when he was with Tampa Bay. Arozarena was the runner-up to Vladimir Guerrero Jr. in the 2023 Home Run Derby.

Rays right-hander Drew Rasmussen, a first-time All-Star, is replacing Angels left-hander Yusei Kikuchi, who is scheduled to start Saturday night at Arizona. Rasmussen is 7-5 with a 2.82 ERA in 18 starts.

San Diego added a third NL All-Star reliever in lefty Adrián Morejón, who replaces Philadelphia starter Zack Wheeler. The Phillies’ right-hander is scheduled to start at San Diego on Saturday night. Morejón entered the weekend with a 1.71 ERA in 45 appearances.

Continue Reading

Sports

M’s Raleigh hits 2 more HRs, brings total to 38

Published

on

By

M's Raleigh hits 2 more HRs, brings total to 38

DETROIT — Cal Raleigh hit his 37th and 38th home runs in Seattle‘s 12-3 victory over Detroit on Friday night to move within one of Barry Bonds’ 2001 major league record for homers before the All-Star break.

Raleigh hit a solo homer off former teammate Tyler Holton in the eighth to tie the American League record of 37 before the All-Star break set by Reggie Jackson in 1969 and matched by Chris Davis in 2013.

“[Holton] and I are really good friends, and I’ve caught a lot of his pitches,” said Raleigh, who was in the lineup as the designated hitter instead of at catcher. “I don’t think that helped much, but I’m sure he’s not very happy with me.”

Raleigh hit a grand slam off Brant Hurter in the ninth.

“I didn’t even know it was a record until just now,” Raleigh said. “I don’t have words for it, I guess. I’m just very grateful and thankful.”

It was Raleigh’s eighth multihomer game this season, tying Jackson (also in 1969) for the most such games before the All-Star break in MLB history, according to ESPN Research. He also tied Ken Griffey Jr. for the most multihomer games in Mariners franchise history.

Seattle has two games left in Detroit before the break.

“Cal Raleigh … this is just unbelievable,” Mariners manager Dan Wilson said. “He’s already set the AL record and now he’s only one short of Barry. There are two games, so who knows?”

Raleigh hit 10 homers in March and April, 12 in May, 11 in June and has five in July.

“This is a very boring comment, but baseball is all about consistency,” Wilson said. “This hasn’t been one hot streak, he’s doing this month after month. That says everything.”

The Associated Press contributed to this report.

Continue Reading

Sports

Bellinger goes deep for 3rd time after Cubs rob HR

Published

on

By

Bellinger goes deep for 3rd time after Cubs rob HR

NEW YORK — Robbed an inning earlier, Cody Bellinger wasn’t sure his first three-homer game had been swiped away again.

“I didn’t know at first,” he said. “For that third one to finally get over feels pretty good.”

Bellinger hit three two-run homers against his former team and was denied a fourth by a spectacular catch, leading the Yankees to an 11-0 rout of the Chicago Cubs on Friday night.

Aaron Judge made a trio of outstanding grabs in right field for the Yankees, who have won five straight games following a a six-game losing streak.

Bellinger, whose dad Clay played for the Yankees from 1999 to 2001, is a two-time All-Star and 2019 NL MVP.

He spent 2023 and 2024 with the Cubs, hitting .266 with 18 homers and 78 RBIs in 130 games last year while missing time because of a broken right rib. The Cubs traded him to New York in December with $52.5 million remaining on his contract and agreed to pay the Yankees $5 million.

He homered in a three-run third off Chris Flexen and in the fifth against Caleb Thielbar for this 18th multihomer game. Bellinger nearly went deep in the seventh but was robbed by Kyle Tucker on a drive above the right-field wall.

“I was watching it. He timed it up perfect, so I was a little sick about it, honestly,” Bellinger said. “But it was a good catch.”

“Boys were giving me a hard time after he robbed it. Boonie was giving me hard time,” Bellinger added.

A four-time All-Star and a Gold Glove winner, Tucker snatched the ball as a fan tried for it, the spectator clasping both sides of the outfielder’s glove.

“I caught the ball and he caught my glove, so I figured even if I dropped it they’d probably look at it and get it overturned,” Tucker said. “I’ve probably had some encounters with me trying to go into the stands and catching a ball and me hitting someone’s hand or whatever but I don’t know if anyone’s ever actually kind of caught my glove while doing it.”

Bellinger homered in the eighth off Jordan Wicks, just above the red glove of leaping center fielder Pete Crow-Armstrong and into the dark glove of a kid in the front row.

“The fan just beat to the spot,” Crow-Armstrong said. “He just had a better chance of catching it higher than I did.”

Bellinger, who had rounded first, watched and then smiled when he saw he had hit No. 3.

“Glad the fan caught it before PCA could grab it,” said Bellinger, who met the boy after and got the ball back. “I’ve seen PCA rob so many homers. He’s a freak athlete out there.”

Bellinger is batting .406 over a career-high 16-game hitting streak, raising his average to .285 with 16 homers and 54 RBIs.

He had spoken with his Cubs ex-teammates during batting practice.

“No, no, no revenge,” he said. “Honestly, ultimately it was just fun to be out there. I saw a bunch of guys I hadn’t seen in a while and I shared a bunch of good memories with them for these past two years.”

Jazz Chisholm Jr. and manager Aaron Boone encouraged Bellinger to emerge from the dugout for a curtain call.

“He was a little reluctant, but then the Bell-lin-ger” over the dugout got pretty loud. So I think he succumbed to it,” Boone said. “Belly’s loved being here and loved playing here in a meaningful place to him, going back to his childhood.”

Bellinger turns 30 on Sunday and can opt out of the final season of his contract this fall. With long balls and wide smiles, he seems to have found a home in the Yankees clubhouse.

He tried not to make much of getting the three homers against the Cubs, but Bellinger’s teammates could sense the significance.

“It’s always good to go against your old teammates that you spend a lot of time with, you know, you respect,” Boone said. “To perform right away against them I’m sure probably is a little cherry on top for him.”

Continue Reading

Trending